Does REGORAFENIB Cause Epistaxis? 106 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Epistaxis have been filed in association with REGORAFENIB (Stivarga). This represents 1.1% of all adverse event reports for REGORAFENIB.
106
Reports of Epistaxis with REGORAFENIB
1.1%
of all REGORAFENIB reports
10
Deaths
30
Hospitalizations
How Dangerous Is Epistaxis From REGORAFENIB?
Of the 106 reports, 10 (9.4%) resulted in death, 30 (28.3%) required hospitalization, and 1 (0.9%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which REGORAFENIB Alternatives Have Lower Epistaxis Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR